Mirae Asset Global Investments
ARCT icon

Mirae Asset Global Investments’s Arcturus Therapeutics ARCT Stock Holding History

Mirae Asset Global Investments’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.54K Sell
1,271
-211
-14% -$1.66K ﹤0.01% 1585
2026
Q1 		$11.4K Buy
1,482
+101
+7% +$737 ﹤0.01% 1489
2025
Q4 		$8.47K Buy
1,381
+331
+32% +$3.58K ﹤0.01% 1609
2025
Q3 		$19.4K Buy
1,050
+2
+0.2% +$32 ﹤0.01% 1498
2025
Q2 		$13.6K Buy
1,048
+142
+16% +$1.68K ﹤0.01% 1446
2025
Q1 		$10.5K Buy
906
+3
+0.3% +$48 ﹤0.01% 1468
2024
Q4 		$15.4K Sell
903
-75
-8% -$1.41K ﹤0.01% 1457
2024
Q3 		$21.5K Buy
978
+174
+22% +$3.72K ﹤0.01% 1423
2024
Q2 		$19.7K Sell
804
-14,269
-95% -$433K ﹤0.01% 1380
2024
Q1 		$335K Sell
15,073
-2,496
-14% -$88.4K ﹤0.01% 2064
2023
Q4 		$554K Sell
17,569
-376
-2% -$8.94K ﹤0.01% 1911
2023
Q3 		$458K Sell
17,945
-1,126
-6% -$34.7K ﹤0.01% 1928
2023
Q2 		$536K Buy
19,071
+2,813
+17% +$76.6K ﹤0.01% 1916
2023
Q1 		$390K Buy
16,258
+6,039
+59% +$108K ﹤0.01% 2046
2022
Q4 		$173K Buy
10,219
+7
+0.1% +$122 ﹤0.01% 2334
2022
Q3 		$152K Buy
+10,212
New +$171K ﹤0.01% 2420

Other funds holding ARCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Mirae Asset Global Investments's ARCT Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Arcturus Therapeutics (ARCT) stake by 14% in Q2 2026, selling an estimated $1.66K and leaving 1,271 shares worth $8.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Mirae Asset Global Investments first reported a position in ARCT in Q3 2022 and has held it in 16 quarters since. The position peaked at $554K in Q4 2023. 48 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Mirae Asset Global Investments held 1,271 shares of Arcturus Therapeutics worth $8.54K as of Q2 2026.
  • Mirae Asset Global Investments sold 211 Arcturus Therapeutics shares in Q2 2026, an estimated $1.66K.
  • Arcturus Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1585 holding.
  • Mirae Asset Global Investments first reported a position in Arcturus Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Arcturus Therapeutics position peaked at $554K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.